It has been shown that TB patients who have negative sputum smears post treatment have significantly lower levels of plasma IL-17, higher levels of plasma IL-10, and higher percentages of Tregs when compared to sputum positive individuals, potentially pointing to a role of Tregs in controlling TB progression (Xu et al., 2016). The gene discussed is IL17A; the disease is tuberculosis.